MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-28-2026
CareDx, Inc P/S Ratio 2011-2026 | CDNA
Annual P/S Ratio CareDx, Inc
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.61 | 2.95 | 1.86 | 2.43 | 8.02 | 17.5 | 8.02 | 12.5 | 2.95 | 1.02 | 2.07 | 1.5 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 17.5 | 1.02 | 5.29 |
P/S Ratio of other stocks in the Diagnostics research industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Myriad Genetics
MYGN
|
0.496 | $ 4.11 | -18.29 % | $ 381 M |  USA |
 |
National Research Corporation
NRC
|
2.29 | $ 17.86 | -4.7 % | $ 400 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
1.7 | $ 27.23 | 2.95 % | $ 20 B |  Niderland |
 |
Centogene N.V.
CNTG
|
1.72 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Burning Rock Biotech Limited
BNR
|
6.87 | $ 17.01 | -0.09 % | $ 179 M |  China |
 |
Agilent Technologies
A
|
6.64 | $ 117.69 | 0.14 % | $ 35.8 B | USA |
|
Akumin
AKU
|
0.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
5.55 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
13.5 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
0.229 | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
5.71 | - | - | $ 562 M |  Britain |
 |
Chembio Diagnostics
CEMI
|
0.254 | - | 0.22 % | $ 16.8 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
0.469 | - | -20.0 % | $ 1.06 M | USA |
 |
Co-Diagnostics
CODX
|
9.4 | $ 1.64 | 3.14 % | $ 2.18 M | USA |
 |
Castle Biosciences
CSTL
|
1.37 | $ 24.75 | 0.61 % | $ 687 M | USA |
 |
Global Cord Blood Corporation
CO
|
0.196 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
3.48 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
1.36 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
2.9 | - | 0.12 % | $ 80.1 M | China |
 |
Medpace Holdings
MEDP
|
5.12 | - | - | $ 12.3 B | USA |
 |
DermTech
DMTK
|
2.77 | - | -11.32 % | $ 2.94 M | USA |
 |
Charles River Laboratories International
CRL
|
1.92 | $ 181.73 | -1.97 % | $ 9.01 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
2.47 | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
0.0018 | - | -8.98 % | $ 14.8 K | USA |
 |
NeoGenomics
NEO
|
2.04 | $ 8.89 | 0.34 % | $ 1.14 B | USA |
 |
Exact Sciences Corporation
EXAS
|
6 | - | - | $ 19.8 B | USA |
 |
Natera
NTRA
|
6.47 | $ 215.09 | 4.02 % | $ 21.2 B | USA |
 |
Fulgent Genetics
FLGT
|
1.65 | $ 14.92 | 0.13 % | $ 451 M | USA |
 |
Personalis
PSNL
|
3 | $ 6.07 | 9.17 % | $ 360 M | USA |
 |
Guardant Health
GH
|
13.7 | $ 92.25 | 3.05 % | $ 11.6 B | USA |
 |
Heska Corporation
HSKA
|
3.28 | - | - | $ 1.31 B | USA |
 |
Soleno Therapeutics
SLNO
|
10.9 | $ 52.94 | 0.04 % | $ 2.69 B | USA |
 |
ICON Public Limited Company
ICLR
|
3.25 | $ 124.13 | 2.32 % | $ 10.2 B |  Irlanda |
 |
Illumina
ILMN
|
3.75 | $ 142.58 | 2.52 % | $ 22.7 B | USA |
 |
Senseonics Holdings
SENS
|
9.94 | $ 5.36 | 7.2 % | $ 224 M | USA |
 |
Interpace Biosciences
IDXG
|
0.19 | - | - | $ 9.33 M | USA |
 |
QIAGEN N.V.
QGEN
|
5.03 | - | - | $ 10.6 B | Niderland |
 |
Thermo Fisher Scientific
TMO
|
4.4 | $ 472.95 | 1.33 % | $ 178 B | USA |
 |
Biomerica
BMRA
|
1.35 | $ 2.21 | 1.14 % | $ 5.08 M | USA |
 |
Trinity Biotech plc
TRIB
|
3.15 | $ 0.6 | 0.42 % | $ 61.9 M | Irlanda |
 |
Lantheus Holdings
LNTH
|
3.32 | $ 86.15 | 0.38 % | $ 5.81 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.71 | $ 256.94 | -0.08 % | $ 21.4 B | USA |
 |
Twist Bioscience Corporation
TWST
|
4.15 | $ 59.53 | 4.99 % | $ 3.56 B | USA |
 |
Motus GI Holdings
MOTS
|
3.1 | - | -34.28 % | $ 263 K |  Israel |
 |
Neogen Corporation
NEOG
|
1.14 | $ 9.18 | -0.97 % | $ 1.99 B | USA |
 |
Waters Corporation
WAT
|
21.1 | $ 349.53 | 1.98 % | $ 20.8 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
2.11 | $ 189.13 | -0.9 % | $ 21 B | USA |